12 studies found for:    "Hypophosphatasia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Extension Study of Protocol ENB-002-08 - Study of Asfotase Alfa in Infants and Young Children With Hypophosphatasia (HPP)
Condition: Hypophosphatasia
Intervention: Biological: asfotase alfa
2 Completed Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP)
Condition: Hypophosphatasia
Intervention: Drug: BPS804
3 Recruiting Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
Condition: Hypophosphatasia (HPP)
Intervention:
4 Recruiting Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
Condition: Hypophosphatasia (HPP)
Intervention:
5 Completed A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)
Condition: Hypophosphatasia (HPP)
Intervention:
6 Active, not recruiting Extension Study of Protocol ENB-006-09 -Asfotase Alfa Treatment in Children With Hypophosphatasia
Condition: Hypophosphatasia
Intervention: Biological: Asfotase Alfa
7 Completed
Has Results
Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)
Condition: Hypophosphatasia
Intervention: Biological: Asfotase Alfa
8 Withdrawn Safety and Efficacy Study of ENB-0040 in Juvenile Patients With Hypophosphatasia (HPP)
Condition: Hypophosphatasia
Intervention: Biological: ENB-0040
9 Completed
Has Results
Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)
Condition: Hypophosphatasia
Intervention: Biological: Asfotase Alfa
10 Active, not recruiting Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
Condition: Hypophosphatasia
Intervention: Drug: Asfotase Alfa
11 Recruiting Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)
Condition: Hypophosphatasia
Intervention: Drug: asfotase alfa
12 Completed Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Condition: Hypophosphatasia
Intervention: Biological: Asfotase Alfa

Indicates status has not been verified in more than two years